When are the treatment sessions and how much time will they take?
The study lasts about 5 weeks with a visit about once a week. Then there are two follow-up assessments 1 week and 1 month after the end of the study.
What are possible risks associated with the study?
The routine medical and laboratory test will evaluate the safety of the procedures, your medication use, and drug allergies. There are no expected risks associated with the interviews or psychological tests other than possible discomfort involved in answering some of the questions. The CBT (therapy) offered might make some individuals anxious when discussing trauma, but your therapist will work with you to make the experience manageable. D-cycloserine has been used in previous studies with individuals with various disorders. Mild side effects are most commonly related with doses greater than 500mg/day, which is ten times the amount that you would receive.
Is this individual or group treatment?
All treatment is done in an individual format. Each session is 90-120 minutes and treatment is done by trained therapists. You will receive periodic evaluations throughout the study that will be conducted individually with one of the study clinicians.
Will I be able to choose which medication I receive?
No, you will be randomly assigned to one of the medicationconditions. However, you will receive regular evaluations of your progress regardless of your medication condition.
How do I know if I am eligible for the study?
The best way to find out whether this study is a good fit for you is to call us at 617-358-2250. We will ask you some preliminary questions about your concerns, and may schedule a more in-depth assessment at our clinic if it seems like the study may be a good fit
Where do the study visits occur?
All study visits occur at Boston University’s Center for Anxiety and Related Disorders at 900 Commonwealth Ave, Boston, MA. We are located right next to the St. Paul Street B-Line T-stop for easy access by public transportation.
Will I be compensated for my participation?
This study is not suited for people who are primarily interested in compensation, but rather for people who have difficulties with Post-Traumatic Stress and are interested in getting treatment for those problems. However, we do offer compensation for the assessment visits.